申请人:Corsair Pharma, Inc.
公开号:US20150166503A1
公开(公告)日:2015-06-18
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
式子 I、II、III 和 IV 所代表的化合物包括替前列环素和前列环素类似物的前药。用途包括治疗肺高压(PH)或肺动脉高压(PAH)。这些化合物的结构可以根据适当的治疗剂量适应特定的应用。可以使用经皮应用。